Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pasello

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Critical Reviews in Oncology/Hematology|September 12, 2015
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatmentLoredana Urso, Fiorella Calabrese, Adolfo Favaretto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2016
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with AfatinibStefano Frega, PierFranco Conte, Matteo Fassan, et al.
Frontiers in Oncology|September 3, 2019
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and PerspectivesIlaria Cavallari, Loredana Urso, Evgeniya Sharova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2018
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After RadiotherapyLaura Bonanno, Alberto Pavan, Ilaria Attili, et al.
Critical Reviews in Oncology/Hematology|July 1, 2018
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?Stefano Frega, Laura Bonanno, Valentina Guarneri, et al.
Critical Reviews in Oncology/Hematology|March 3, 2009
Second and third line treatment in non-small cell lung cancerAdolfo Favaretto, Giulia Pasello, Cristina Magro, et al.
International Journal of Molecular Sciences|May 27, 2023
Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical NeedGiulia Pretelli, Calogera Claudia Spagnolo, Giuliana Ciappina, et al.
Journal of Thoracic Disease|January 21, 2012
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case reportGiulia Pasello, Giuseppe Altavilla, Laura Bonanno, et al.
International Journal of Molecular Sciences|March 1, 2020
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for TreatmentStefano Frega, Alessandra Ferro, Laura Bonanno, et al.
European Journal of Dermatology : EJD|March 3, 2017
Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumabIrene Russo, Giorgia Sacco, Stefano Frega, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Critical Reviews in Oncology/Hematology|September 12, 2015
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatmentLoredana Urso, Fiorella Calabrese, Adolfo Favaretto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2016
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with AfatinibStefano Frega, PierFranco Conte, Matteo Fassan, et al.
Frontiers in Oncology|September 3, 2019
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and PerspectivesIlaria Cavallari, Loredana Urso, Evgeniya Sharova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2018
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After RadiotherapyLaura Bonanno, Alberto Pavan, Ilaria Attili, et al.
Critical Reviews in Oncology/Hematology|July 1, 2018
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?Stefano Frega, Laura Bonanno, Valentina Guarneri, et al.
Critical Reviews in Oncology/Hematology|March 3, 2009
Second and third line treatment in non-small cell lung cancerAdolfo Favaretto, Giulia Pasello, Cristina Magro, et al.
International Journal of Molecular Sciences|May 27, 2023
Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical NeedGiulia Pretelli, Calogera Claudia Spagnolo, Giuliana Ciappina, et al.
Journal of Thoracic Disease|January 21, 2012
A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case reportGiulia Pasello, Giuseppe Altavilla, Laura Bonanno, et al.
International Journal of Molecular Sciences|March 1, 2020
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for TreatmentStefano Frega, Alessandra Ferro, Laura Bonanno, et al.
European Journal of Dermatology : EJD|March 3, 2017
Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumabIrene Russo, Giorgia Sacco, Stefano Frega, et al.
Pageof 17